Fonar Corporation (FONR) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Fonar Corporation stock (FONR) is currently trading at $18.59. Fonar Corporation PE ratio is 13.27. Fonar Corporation PS ratio (Price-to-Sales) is 1.09. WallStSmart rates FONR as Sell.
- FONR PE ratio analysis and historical PE chart
- FONR PS ratio (Price-to-Sales) history and trend
- FONR intrinsic value — DCF, Graham Number, EPV models
- FONR stock price prediction 2025 2026 2027 2028 2029 2030
- FONR fair value vs current price
- FONR insider transactions and insider buying
- Is FONR undervalued or overvalued?
- Fonar Corporation financial analysis — revenue, earnings, cash flow
- FONR Piotroski F-Score and Altman Z-Score
- FONR analyst price target and Smart Rating
Fonar Corporation
📊 No data available
Try selecting a different time range
FONR Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · Fonar Corporation (FONR)
FONR trades 146% above its Graham fair value of $7.55, indicating the stock may be overvalued at current levels.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
Fonar Corporation (FONR) · 9 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/sales, price/book. Concerns around market cap and return on equity. Mixed signals suggest waiting for clearer direction before acting.
Fonar Corporation (FONR) Key Strengths (2)
Trading below book value, meaning the market prices it less than net assets
Paying $1.09 for every $1 of annual revenue
Supporting Valuation Data
Fonar Corporation (FONR) Areas to Watch (7)
Earnings declining -29.20%, profits shrinking
Revenue growing slowly at 4.30% annually
Micro-cap company with very limited liquidity and high volatility
Low profitability relative to shareholder equity
Thin operating margins with cost pressures present
Thin profit margins with limited profitability
Moderate institutional interest at 47.42%
Fonar Corporation (FONR) Detailed Analysis Report
Overall Assessment
This company scores 42/100 in our Smart Analysis, earning a D grade. Out of 9 metrics analyzed, 2 register as strengths (avg 9.0/10) while 7 fall into concern territory (avg 3.1/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Book, Price/Sales. Valuation metrics including Price/Sales (1.09), Price/Book (0.65) suggest the stock is attractively priced.
The Bear Case
The primary concerns are EPS Growth, Revenue Growth, Market Cap. Growth concerns include Revenue Growth at 4.30%, EPS Growth at -29.20%, which may limit upside. Profitability pressure is visible in Return on Equity at 5.84%, Operating Margin at 12.30%, Profit Margin at 7.08%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether EPS Growth improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 5.84% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 4.30% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. EPS Growth and Revenue Growth are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
FONR Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
FONR's Price-to-Sales ratio of 1.09x sits near its historical average of 0.98x (58th percentile), suggesting the market is pricing in steady-state growth. The current valuation is 62% below its historical high of 2.84x set in Feb 2014, and 2084% above its historical low of 0.05x in Feb 2007.
Compare FONR with Competitors
Top DIAGNOSTICS & RESEARCH stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for Fonar Corporation (FONR) · HEALTHCARE › DIAGNOSTICS & RESEARCH
The Big Picture
Fonar Corporation is in a high-growth phase, prioritizing rapid expansion over margins. Revenue reached 105M with 430% growth year-over-year. Profit margins are thin at 7.1%, typical for companies in this phase that are reinvesting heavily in growth.
Key Findings
Revenue growing at 430% YoY, reaching 105M. This pace significantly outperforms most DIAGNOSTICS & RESEARCH peers.
ROE of 584.0% means the company generates strong returns on shareholder equity. Above 20% is considered top-tier.
Free cash flow is -268,000, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.
What to Watch Next
Margin expansion: can Fonar Corporation push profit margins above 15% as the business scales?
Growth sustainability: can Fonar Corporation maintain 430%+ revenue growth, or will competition slow it down?
Sector dynamics: monitor DIAGNOSTICS & RESEARCH industry trends, competitive moves, and regulatory changes that could impact Fonar Corporation.
Bottom Line
Fonar Corporation is a high-conviction growth story with revenue accelerating at 430% while profitability is still developing. For growth-oriented investors, the trajectory is compelling. For value investors, the thin 7.1% margins and premium valuation suggest patience until the unit economics mature further.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Data sourced from SEC Form 4 filings
Last updated: 8:25:30 AM
About Fonar Corporation(FONR)
NASDAQ
HEALTHCARE
DIAGNOSTICS & RESEARCH
USA
FONAR Corporation is engaged in the research, development, production, and marketing of Magnetic Resonance Imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company is headquartered in Melville, New York.